Medicare Enrolled
Dr. Latha Sree Polavaram, MD
Hematology & Oncology · Grand Rapids, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Polavaram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Polavaram?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Polavaram
Dr. Latha Sree Polavaram is a hematology & oncology specialist in Grand Rapids, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Polavaram performed 57,627 Medicare services across 2,358 unique beneficiaries.
Between the years covered by Open Payments, Dr. Polavaram received a total of $5,195 from 45 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Polavaram is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in MI
$5,195 industry payments
Medicare Practice Summary
Medicare Utilization ↗57,627
Medicare services
Top 10% in MI for hematology & oncology
2,358
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,033 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
18,750 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
16,740 | $2 | $5 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
9,900 | $0 | $5 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,570 | $4 | $70 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,152 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,139 | $8 | $26 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,082 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
782 | $10 | $35 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
560 | $9 | $32 |
| Anti-nausea injection (Aloxi/palonosetron) | 400 | $1 | $36 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
378 | $6 | $20 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
374 | $17 | $43 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $89 | $189 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
197 | $76 | $70 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
190 | $11 | $34 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
170 | $10 | $37 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
170 | $89 | $180 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
168 | $55 | $133 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
166 | $52 | $123 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
160 | $95 | $292 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
147 | $127 | $264 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
118 | $10 | $38 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
115 | $21 | $47 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
89 | $4 | $15 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
85 | $16 | $55 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
69 | $5 | $14 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
62 | $13 | $46 |
| Iron level test | 60 | $6 | $22 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
60 | $41 | $151 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
49 | $35 | $89 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
44 | $12 | $40 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
43 | $15 | $41 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
36 | $7 | $23 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
35 | $1 | $2 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
34 | $25 | $81 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
33 | $16 | $57 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
31 | $47 | $142 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
29 | $15 | $51 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
28 | $10 | $26 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
27 | $12 | $30 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
25 | $4 | $13 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
25 | $11 | $27 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
24 | $5 | $16 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
21 | $61 | $126 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
20 | $21 | $62 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
19 | $14 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $134 | $304 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
15 | $88 | $236 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
13 | $4 | $11 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
33.0% high complexity
56.1% medium
10.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,195
Total received (2018-2024)
Avg $742/year across 7 years
Top 30% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,115 (60.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,440 (27.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$640 (12.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$417
2023
$825
2022
$1,161
2021
$1,744
2020
$89
2019
$666
2018
$293
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$99
AstraZeneca Pharmaceuticals LP
$46
ABBVIE INC.
$46
Novartis Pharmaceuticals Corporation
$39
ARRAY BIOPHARMA INC
$37
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
Amneal Pharmaceuticals LLC
$29
Takeda Pharmaceuticals U.S.A., Inc.
$28
Eisai Inc.
$27
GlaxoSmithKline, LLC.
$18
E.R. Squibb & Sons, L.L.C.
$17
Top 3 companies account for 45.7% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$1,476
Janssen Biotech, Inc.
$312
AstraZeneca Pharmaceuticals LP
$309
Celgene Corporation
$257
Amgen Inc.
$255
ARRAY BIOPHARMA INC
$224
Alexion Pharmaceuticals, Inc.
$199
Novartis Pharmaceuticals Corporation
$172
PFIZER INC.
$145
Genentech USA, Inc.
$138
Takeda Pharmaceuticals U.S.A., Inc.
$132
Pharmacyclics LLC, An AbbVie Company
$132
GlaxoSmithKline, LLC.
$130
Ipsen Biopharmaceuticals, Inc
$123
Gilead Sciences, Inc.
$115
GENZYME CORPORATION
$113
ABBVIE INC.
$109
EISAI INC.
$88
Pharmacyclics LLC, an AbbVie Company
$73
Lilly USA, LLC
$51
Seagen Inc.
$50
Kite Pharma, Inc.
$50
Kyowa Kirin, Inc.
$47
E.R. Squibb & Sons, L.L.C.
$41
Agios Pharmaceuticals, Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$39
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
Amneal Pharmaceuticals LLC
$29
EMD Serono, Inc.
$29
Eisai Inc.
$27
Astellas Pharma US Inc
$27
Alnylam Pharmaceuticals Inc.
$23
Daiichi Sankyo Inc.
$21
JAZZ PHARMACEUTICALS INC.
$21
PharmaEssentia USA Corporation
$20
Merck Sharp & Dohme LLC
$19
Bayer Healthcare Pharmaceuticals Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme Corporation
$15
Sumitomo Pharma America, Inc.
$15
TG Therapeutics, Inc.
$14
TAIHO ONCOLOGY, INC.
$14
Mylan Pharmaceuticals Inc.
$13
Karyopharm Therapeutics Inc.
$13
Verastem, Inc.
$12
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AVASTIN · Alecensa · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Balversa · Bavencio · CALQUENCE · CYRAMZA · Copiktra · DARZALEX · ENHERTU · ENJAYMO · EPKINLY · EXKIVITY · Erleada · Fabhalta · Fulphila · GIVLAARI · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KYMRIAH · Kyprolis · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · NINLARO · Nplate · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Odomzo · Onivyde · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · Pomalyst · Poteligeo · REBLOZYL · SARCLISA · SOLIRIS · SOMATULINE DEPOT · Stivarga · TAGRISSO · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · XALKORI · XENPOZYME · XPOVIO · XTANDI · Xospata · Yescarta · ZEPZELCA · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
23
Per 100K population
3.5
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Polavaram is a mixed practice specialist, with above-average Medicare volume (top 10% in MI), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Polavaram experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Polavaram performed 18,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Polavaram receive payments from pharmaceutical companies?
Yes. Dr. Polavaram received a total of $5,195 from 45 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Polavaram's costs compare to other hematology & oncology specialists in Grand Rapids?
Dr. Polavaram's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Polavaram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Grand Rapids
Browse hematology & oncology specialists in Grand Rapids ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology